HomeEXECUTIVES

EXECUTIVES

Sphere Fluidics Appoints Curtis Nicholson as Director of Sales, EMEA, to Support Accelerated Growth in Key Markets

Curtis Nicholson said “I’m thrilled to leverage my experience in strategic sales and driving innovation to take on this exciting role at Sphere Fluidics. I look forward to collaborating with the talented team and accelerating the adoption of our transformative solutions.”

Fiona Coats Appointed Chief Marketing Officer at Refeyn

Fiona Coats will bring with her a wealth of experience from over 25 years in the biotechnology sector. Her extensive background in science, combined with a proven track record of driving growth and innovation, positions her as a respected leader in the life science research market.

Simona Skerjanec Appointed to the BOD at Avidity Biosciences

Simona Skerjanec has led multiple research and development efforts that have resulted in regulatory approvals and launches of commercial therapies in therapeutic areas including neurology and cardiology in the U.S. and other countries.

Patrick Clysdale Joins Direct Sales Team at Herculite Products

Patrick Clysdale Patrick Clysdale will manage the company's Direct Sales team's southeastern region, which includes automotive, custom-engineered solutions, healthcare, agriculture, and tent and structure customers.

Dr Cheryl Pegus Elected to the Boston Scientific Board of Directors

Dr Cheryl Pegus has more than 25 years of clinical and business leadership experience, most recently serving as a partner at Morgan Health focused on improving the quality, affordability and equity of health care.

Joe Gabler Appointed Chief Growth Office at Paytient

Joe Gabler is a senior executive and healthcare consumer payments pioneer with nearly 20 years of experience building companies around winning cultures. Joe will join Paytient to drive growth and expansion as the company continues to partner with leading employers, payers, and PBMs.

Avation Medical Adds Vice President of Market Access

“Adding Michael to the Avation leadership team is our next step in launching Vivally,” said Jill Schiaparelli, founder and CEO of Avation Medical. “Patients have been crystal clear that they want a surgical-free, non-invasive treatment option for their OAB symptoms. Our focus now is to ensure that Vivally is easily accessible to the 46 million patients suffering from OAB in this country.”

Xeno Biosciences Welcomes New CEO, Dennis D. Kim, MD, MBA Plus Secures Funding

Dennis has an extraordinary depth of knowledge and is highly respected in the obesity field; I could not imagine anyone more perfect to lead our company,” said Jeff Arnold, Chairman and a Director at Xeno Biosciences since 2017.

Peter Eckes, Former CTO of BASF Agricultural Solutions, to Chair Harpe Bioherbicide Board

Peter Eckes offers more than a 30-year career in the agricultural industry, and provides a unique appreciation for what it takes to bring innovation to the modern agriculture marketplace at scale without losing sight of farmer and consumer needs.
Exit mobile version